Ucb Biopharma Srl

This study tested a drug called bimekizumab in 133 Chinese adults with moderate to severe plaque psoriasis. Participants received either the drug or a placebo for 16 weeks. The main goal was to see if bimekizumab could significantly clear skin compared to placebo. This is a disea…

This study looked at whether people with generalized myasthenia gravis (a condition causing muscle weakness) can safely and effectively give themselves the drug zilucoplan using a new auto-injector device. Thirty-one adults who were already taking zilucoplan participated. The mai…

This study tested a new drug called bimekizumab in 567 adults with moderate to severe plaque psoriasis. The goal was to see if it could clear skin better than a placebo or an existing treatment. Participants received injections and were monitored for improvement in skin redness, …

This study tested a new medicine called UCB9741 in healthy volunteers and people with moderate-to-severe atopic dermatitis (eczema). The main goal was to check if the drug is safe and how the body processes it. Researchers also looked for early signs that the drug might improve e…

This study tested a drug called bimekizumab in 509 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps under the skin. The goal was to see if the drug could reduce the number of abscesses and inflamed bumps by at least 50% a…

This study tested a drug called bimekizumab in 505 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps. Participants received either the drug or a placebo. The main goal was to see if the drug could reduce skin lesions by at…

This study looked at whether 62 people with generalized myasthenia gravis could learn to give themselves the drug rozanolixizumab at home using a syringe driver or manual push. After training, most participants successfully self-administered the correct dose at the right site. Th…

This study looked at how the drug bimekizumab works in the bodies of teenagers aged 12 to 17 with moderate to severe plaque psoriasis. Researchers measured drug levels in the blood over time and tracked any side effects. The goal was to find the right dose and confirm the drug is…

This study tested whether adding brivaracetam to existing epilepsy medications could safely reduce partial seizures in adults aged 16 to 80. Over 400 participants took either the drug or a placebo for 12 weeks. The main goals were to check for side effects and measure how much se…

This study tested a new medicine called UCB1381 in healthy people and those with moderate to severe eczema (atopic dermatitis). The main goals were to see if the drug is safe and to measure how well it clears skin rashes compared to a placebo. The trial involved 273 participants …

This study tested a drug called bimekizumab in 332 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either the drug or a placebo injection. The main goal was to see if the drug improved symptoms by at least …

This study tested a new medicine called bimekizumab in 852 adults with active psoriatic arthritis, a condition causing joint pain and swelling. Participants received either bimekizumab, a placebo (inactive shot), or an existing drug (adalimumab) to compare effectiveness and safet…

This study tested a drug called bimekizumab in 400 adults with active psoriatic arthritis who had not responded well to standard TNF-blocking treatments. The goal was to see if bimekizumab could reduce joint pain and swelling better than a placebo. Participants received injection…

This study tested a new drug called bimekizumab against an existing treatment (adalimumab) in 478 adults with moderate to severe plaque psoriasis. The main goal was to see how many people achieved at least 90% clearer skin after 16 weeks of treatment. The trial also looked at lon…

This study tested an experimental drug called UCB0022 in 207 people with advanced Parkinson's disease. The goal was to see if adding UCB0022 to their usual treatment could reduce the daily hours when Parkinson's symptoms return (OFF time). Participants were randomly assigned to r…

This study tested how quickly Staccato alprazolam (an inhaled sedative) affects brain activity compared to two other sedatives given by IV or nasal spray. Fifty-five healthy adults received single doses and had their brain waves measured. The goal was to see which drug acts faste…

This early-stage study tested a single dose of the experimental drug UCB9741 in 40 healthy adults (Caucasian and Japanese) to check its safety and how the body processes it. Participants received either the drug or a placebo by injection. The goal was not to treat any disease, bu…

This early-stage study tested the safety and how the body processes a single dose of donzakimig in 32 healthy Chinese and Japanese adults. Participants received either the drug or a placebo, and researchers monitored for side effects and drug levels in the blood. Since this is a …

This study looked at whether giving the drug zilucoplan by a prefilled syringe or an auto-injector leads to similar levels in the blood. It involved 14 healthy adults aged 18 to 55. The goal was to check if both methods work the same, not to treat any disease.

This study looked at how much of the drug rozanolixizumab appears in breast milk after a single dose. Fifteen healthy lactating women who had already decided to stop breastfeeding took part. Researchers collected milk samples over 7 days to measure drug levels and estimate how mu…

This study tested two different tablet versions of a drug called UCB0022 in 14 healthy adults aged 18 to 55. The goal was to see how much of the drug gets into the blood and if one tablet works better than the other. Researchers also checked for any side effects. This is an early…

This early-stage study tested two new formulations of the experimental drug UCB0599 in 73 healthy adults. Part A looked at how stomach acid levels affect drug absorption, while Part B checked safety and how the drug behaves in people of Japanese and Chinese descent. The goal was …